| Filed On | Filing |
|---|---|
| 16 Oct 2023 |
8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
Spero Therapeutics, Inc., a Delaware corporation (the “Corporation”), pursuant to Section 103(f) of the Delaware General Corporation Law (“DGCL”), hereby certifies that: |
| 11 May 2020 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 29 Mar 2019 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
Loading...
